News & Analysis on Clinical Trial Services & Contract Research And Development
Reports of a €200m expansion at Sanofi Pasteur's production plant in Rouen, France, have come hot on the heels of news that the US Food and Drug Administration (FDA) has approved the company's vaccine to protect humans against bird flu.
A new integrated dose counter is being launched this week by 3M's drug delivery systems business, providing a new solution to recent regulatory requirements for metered dose inhalers.
Pro-Pharmaceuticals is preparing to submit a New Drug Application (NDA) for its lead product candidate, Davanat, as a functional excipient that promises to hike the efficacy and cut the side effects of cancer drugs.
An increasing number of factors are luring sponsors to offshore clinical trials to 'hidden gems' across the globe, delegates heard at this week's Accelerating Patient Recruitment & Retention in Clinical Trials conference, run by SMi in London.
Canadian contract manufacturer Patheon has announced its plans to restructure its Ontario network of drug manufacturing facilities in order to improve its profitability.
The European Union Patent Office (EPO) has granted UK stem cell experts ReNeuron patent protection for three key human neural stem cell lines.
Pharmaceutical Products Development (PPD) has posted lacklustre results for the first quarter of 2007, with profitability remaining flat.
Drug delivery specialist SCOLR Pharma plans to file a US New Drug Application (NDA) in the latter half of 2008 for a 12-hour tablet formulation of the painkiller ibuprofen.
Sanofi-Aventis' H5N1 bird flu vaccine has won approval from the US Food and Drug Administration (FDA) as a limited protection measure in case of a pandemic.
A combination of new drugs, new patient needs and new technologies is likely to fuel steady growth in the transdermal/transmucosal drug delivery market during the years to 2010.
French contract research organisation (CRO) Porsolt & Partners Pharmacology has signed a co-marketing deal with Singapore-based start-up Maccine to co-promote their respective preclinical service offerings to pharma and biotech companies.